• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: WRIGHTS LANE SYNTHES USA PRODUCTS LLC 14MM TI CANN RETRO/ANTEGRADE FEMORAL NAIL-EX/420MM-STERILE; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

WRIGHTS LANE SYNTHES USA PRODUCTS LLC 14MM TI CANN RETRO/ANTEGRADE FEMORAL NAIL-EX/420MM-STERILE; ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES Back to Search Results
Model Number 04.013.864S
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Nonunion/Delayed-union Bone Fracture (2369)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
It was reported that the patient underwent removal of one (1) ti cannulated antegrade femoral nail and three (3) locking screw on (b)(6) 2021, due to nonunion.There was no surgical delay.The procedure successfully completed.The patient outcome is unknown.This is report 1 of 4 for (b)(4).
 
Additional Manufacturer Narrative
Product complaint (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.H10 additional narrative: d10: concomitant devices reported.H3, h4, h6: device history lot, manufacturing location: monument, manufacturing date: 29-may-2014, expiration date: 30-apr-2023, part number: 04.013.864s, 14mm ti cann retro/antegrade femoral nail-ex/420mm ¿ sterile.Lot number: 7689628 (sterile), lot quantity: 6 , this lot was reworked to perform the verification and the lot was determined to be acceptable; the disposition was ¿release from hold¿.Work order traveler met all inspection acceptance criteria.Inspection sheet, in-process / inspect dimensional / final, acceptance, met all inspection acceptance criteria.Packaging label log lppf, lmd/lpf rev g was reviewed and determined to be conforming.Packaging bom was reviewed and determined to be conforming with no deviations to normal packaging identified.Scn 10268 supplied by (b)(4) (abq) was reviewed and determined to be conforming.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Component part(s) reviewed: component parts were not reviewed as the reported complaint condition of ¿removal due to non-union¿ does not indicate breakage of the nail.Therefore, review of the raw material would not be pertinent to the reported complaint condition.Device history batch null, device history review 04-feb-2021: dhr reviewed.This lot met all dimensional, visual, sterility and packaging criteria at the time of release with no issues documented during the manufacture that would contribute to this complaint condition.Investigation summary: product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
14MM TI CANN RETRO/ANTEGRADE FEMORAL NAIL-EX/420MM-STERILE
Common Device Name
ROD, FIXATION, INTRAMEDULLARY AND ACCESSORIES
Manufacturer (Section D)
WRIGHTS LANE SYNTHES USA PRODUCTS LLC
1302 wrights lane east
west chester PA 19380
MDR Report Key11343097
Report Number2939274-2021-00930
Device Sequence Number17402304
Product Code HSB
UDI-Device Identifier10886982088581
UDI-Public(01)10886982088581
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
PMA/510(K) Number
K033618
Number of Events Summarized1
Summary Report (Y/N)N
Device Explanted Year2021
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 01/28/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/30/2023
Device Model Number04.013.864S
Device Catalogue Number04.013.864S
Device Lot Number7689628
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/28/2021
Supplement Date Received by Manufacturer03/18/2021
Initial Report FDA Received Date02/18/2021
Supplement Report FDA Received Date03/22/2021
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
14 TI CANN RETRO/ANTEGRADE FEM NL/420-S; 6.0 TI LCKNG SCR T25 SD 40 FOR IM NAILS; 6.0 TI LCKNG SCR T25 SD 54 FOR IM NAILS; 6.0 TI LCKNG SCR T25 SD 64 FOR IM NAILS
Outcome Attributed to Adverse Event Required Intervention;
Patient Age55 YR
-
-